Frazier Management LLC Immunovant, Inc. Transaction History

Frazier Management LLC

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$5.06 - $8.77 $2.96 Million - $5.14 Million
-585,759 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$7.01 - $11.37 $2.33 Million - $3.77 Million
331,759 Added 130.61%
585,759 $5.09 Million
Q2 2021

Aug 11, 2021
SELL
$9.4 - $16.85 $2.39 Million - $4.28 Million
-254,000 Reduced 50.0%
254,000 $2.69 Million
Q1 2021

May 12, 2021
BUY
$13.08 - $49.6 $6.64 Million - $25.2 Million
508,000 New
508,000 $8.15 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email